Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Granules India Limited ( (IN:GRANULES) ) is now available.
Granules India Limited has issued a corrigendum to the notice of its Extra-Ordinary General Meeting scheduled for January 22, 2026, which will be held via video conferencing, and has published this corrigendum in the Business Standard and Nava Telangana newspapers as required for shareholder communication and regulatory compliance. The corrigendum relates to clarifications and modifications concerning the proposed preferential issue of convertible warrants and equity shares for which in-principle approvals had been sought from the National Stock Exchange of India and BSE, following observations received from the exchanges, indicating the company is adjusting its capital-raising proposal in line with regulatory feedback ahead of shareholder approval.
More about Granules India Limited
Granules India Limited is a Hyderabad-headquartered pharmaceutical company engaged in the manufacture and sale of bulk drugs, pharmaceutical formulations and related products, serving domestic and international markets from its facilities in India.
Average Trading Volume: 42,218
Technical Sentiment Signal: Buy
Current Market Cap: 146.2B INR
Learn more about GRANULES stock on TipRanks’ Stock Analysis page.